Peptides as a platform for targeted therapeutics for cancer: peptide-drug conjugates (PDCs). (2021)

First Author: Cooper BM

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1039/d0cs00556h

PubMed Identifier: 33346298

Publication URI: http://europepmc.org/abstract/MED/33346298

Type: Journal Article/Review

Volume: 50

Parent Publication: Chemical Society reviews

Issue: 3

ISSN: 0306-0012